方法：随机选择正常肝脏、代偿期和失代偿期肝硬化各100例。
Methods: Normal cases compensated cirrhosis and decompensated cirrhosis each 100 cases respectively were selected at random.
目的：探讨安络化纤丸和还原型谷胱苷肽联合治疗失代偿期肝硬化的临床疗效。
Objective: To investigate the curative effects of An-luo Hua-xian pill and reduced glutathione on decompensated hepatic cirrhosis.
目的：对相关文献进行一项系统综述，来确定HCV相关性代偿期肝硬化的结局。
Aim to perform a systematic review of the literature to establish the outcome of compensated HCV cirrhosis.
目的：探讨在西药综合治疗基础上加用中药“化瘀益气汤”治疗失代偿期肝硬化患者的临床疗效。
Objective:To explore the therapeutic efficacy of Huayu Yiqi Decoction on the basis of western medicine in treatment of decompensatory liver cirrhosis.
目的探讨肝硬化失代偿期老年患者的营养管理方法和效果。
Objective To explore the methods and effect of nutrition management in old patients with liver cirrhosis at decompensation stage.
结论肝硬化失代偿期患者可能存在下丘脑—垂体—性腺轴功能紊乱。
Conclusion There may be dysfunction of hypothalamics-pituitary-gonadal axis system in male patients with cirrhosis decompensation.
结论饮食干预对肝硬化失代偿期的治疗有重要意义，而且对患者的预后也有重要作用。
Conclusion: dietary interventions for the treatment of decompensated cirrhosis is important period, and the prognosis of the patients with also have an important role.
健康教育干预对肝硬化失代偿期患者生活质量的影响。
Effect of health educational intervention on life quality of patients with decompensated liver cirrhosis.
目的：观察二甲胶囊抗肝纤维化、治疗肝硬化(代偿期)的临床疗效和安全性。
Objective: To observe clinical effect and safety that Erjia capsule treated cirrhosis of liver.
目的：探讨肝硬化失代偿期腹水与胆囊壁增厚的临床关系及其诊断价值。
Objective: to investigate the clinical relationship and diagnostic value of ascites and gallbladder wall thickening during hepatocirrhosis decompensation.
拉米夫定治疗乙型肝炎肝硬化失代偿期的临床观察。
Clinical Observation of Lamivudine for Decompensated Cirrhosis Resulting from Chronic Hepatitis b.
目的：探讨肝硬化失代偿期并发自发性细菌性腹膜炎(SBP)危险因素，提高早期诊断率。
AIM: to investigate the risk factors of decompensated cirrhosis complicated with spontaneous bacterial peritonitis (SBP), and to improve the rate for early diagnosis rate.
目的探讨肝硬化失代偿期合并肝性胸水患者的临床特点。
Objective To investigate the clinical features of decompensate cirrhosis patients with pleural effusion.
方法对肝硬化代偿期和失代偿期病人的血糖及胰岛素水平进行为期3年的临床监测，并与正常对照组进行对比分析。
Methods The blood sugar and insulin levels in patients with compensatory phase and decompensatory phase cirrhosis were monitored for 3 years and a comparison to the control group has also been done.
目的探讨脉冲组织多普勒(PW - TDI)评价肝硬化失代偿期右心功能的临床价值。
Objective To investigate the value of PW-TDI for estimating right ventricular function in the patients with hepatic cirrhosis.
结果肝硬化患者血、尿nag水平明显高于正常对照，失代偿期明显高于代偿期。
Results the results indicated that the NAG levels of patients with liver cirrhosis were higher than those of controls.
方法：对酒精性肝硬化代偿期和失代偿期患者及健康者用放射免疫分析法检测细胞因子的含量进行分析。
Methods: The changes in serum cytokine level in compensated and decompensated alcoholic liver cirrhosis patients and healthy controls were measured by radioimmunoassay technique.
结果肝硬化代偿期组患者的血糖及胰岛素水平与正常对照组比较差异无显著性（P>0.05）；
Results The blood sugar and insulin levels in patients with compensatory phase were almost the same with those in the control group, there were no statistically significant difference (P>0.05);
结果：肝硬化失代偿期诱发MOF的主要因素老年组为感染，非老年组为出血，且老年组mOF的发生率、发生衰竭脏器的数目、病死率均高于非老年组。
Results: Infection is a primary factor induced MOF in the group A. But hemorrhage is a primary factor in the group b; there were higher occurrence of MOF and higher morbidity.
结果：肝硬化失代偿期诱发MOF的主要因素老年组为感染，非老年组为出血，且老年组mOF的发生率、发生衰竭脏器的数目、病死率均高于非老年组。
Results: Infection is a primary factor induced MOF in the group A. But hemorrhage is a primary factor in the group b; there were higher occurrence of MOF and higher morbidity.
应用推荐